Did you know that more people play disability football than rugby league in the UK?
The pinnacle of disability sport is the Paralympic Games, and Bournemouth University are pleased to announce some of the major figures in disability football are coming to Disability History month. Both the GB/England captains will be sharing their stories- Keryn Seal (Blind captain) and Jack Rutter (Cerebral Palsy captain), as well as several members of the Rio 2016 Cerebral Palsy Paralympic Football squad (James Blackwell, Liam Irons, Giles Moore, Emyle Rudder). Accompanying them will be Jeff Davis who is National Elite Development Manager for disability football at the Football Association. Jeff has also led the GB football squads at three Paralympic Games, in his role as Performance Director at the 2008, 2012, and 2016 Paralympics.
The talk is part of Disability History Month 2006 and will take place on 5 December 2016, 17:00-18:00
The Disability History Month is a result of collaboration between Bournemouth Univetsity (BU) and Students’ Union Bournemouth University (SUBU).
Look out for #bued1617 hashtag for programme and talk updates.
Click Here to register for this event.











Geography and Environmental Studies academics – would you like to get more involved in preparing our next REF submission?
Reminder: Recharge Your Research Routine Next Week for World Wellbeing Week
Boost Your Research Toolkit: Digital Confidence & AI Literacy Workshop – Friday 26 June 10am-12pm
BU students’ publishing success
BU presentation at the University of Bristol
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease